F5 (FFIV) CEO sells 3,755 shares in Rule 10b5-1 stock plan

Q: At what prices did the F5 (FFIV) CEO sell his shares?

The CEO’s 3,755-share sale was executed in multiple trades with weighted-average prices reported around the high $270s to mid $280s per share. Footnotes state actual prices ranged from $277.99 to $286.71, with detailed breakouts available upon request from the company or SEC staff.

Q: What is the role of the family trust in the F5 (FFIV) CEO’s holdings?

The filing reports 42,000 shares of F5 common stock are held in a trust for the benefit of the CEO’s children. His spouse serves as trustee of this family trust, and these shares are reported as indirect ownership separate from his directly held shares.

Q: Were the F5 (FFIV) CEO’s transactions open-market sales?

Yes. Each listed trade is coded as an “S” transaction in common stock, described as an open-market or private sale . The filing characterizes these as non-derivative sales of F5 common stock executed on March 4, 2026, under the CEO’s Rule 10b5-1 plan.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

F5, INC. President and CEO Francois Locoh-Donou reported open-market sales of 3,755 shares of common stock on March 4, 2026, executed under a Rule 10b5-1 trading plan dated December 3, 2025.

The shares were sold in multiple trades at weighted-average prices generally between $277.99 and $286.71 per share. After these sales, he directly holds 150,323 shares, and an additional 42,000 shares are held indirectly through a family trust for his children.

Insider Trade Summary

Net Seller: 3,755 shares ($1,064,671)

Net Sell 10 txns

Insider Locoh-Donou Francois

Role President, CEO & Director

Sold 3,755 shs ($1.06M)

Type	Security	Shares	Price	Value
Sale	Common Stock	120	$278.12	$33K
Sale	Common Stock	307	$279.7334	$86K
Sale	Common Stock	693	$280.7327	$195K
Sale	Common Stock	280	$281.9943	$79K
Sale	Common Stock	160	$282.71	$45K
Sale	Common Stock	360	$284.1324	$102K
Sale	Common Stock	720	$285.0287	$205K
Sale	Common Stock	995	$286.2013	$285K
Sale	Common Stock	120	$286.67	$34K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 153,958 shares (Direct); Common Stock — 42,000 shares (Indirect, By Family Trust)

Footnotes (1)

This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 12/03/2025. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $277.99 to $278.35. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $279.18 to $280.17. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $280.18 to $281.13. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $281.36 to $282.34. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $282.49 to $283.12. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $283.57 to $284.56. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $284.57 to $285.45. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $285.58 to $286.54. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $286.61 to $286.71. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. These shares are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trust.

Form 4 Insider Transactions: What Each Field Means →

03/05/2026 - 06:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Locoh-Donou Francois

(Last)

(First)

(Middle)

C/O F5, INC.

801 5TH AVENUE

(Street)

SEATTLE

98104

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
F5, INC. [ FFIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, CEO & Director

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/04/2026		S		120⁽¹⁾	D	$278.12⁽²⁾	153,958	D
Common Stock	03/04/2026		S		307⁽¹⁾	D	$279.7334⁽³⁾	153,651	D
Common Stock	03/04/2026		S		693⁽¹⁾	D	$280.7327⁽⁴⁾	152,958	D
Common Stock	03/04/2026		S		280⁽¹⁾	D	$281.9943⁽⁵⁾	152,678	D
Common Stock	03/04/2026		S		160⁽¹⁾	D	$282.71⁽⁶⁾	152,518	D
Common Stock	03/04/2026		S		360⁽¹⁾	D	$284.1324⁽⁷⁾	152,158	D
Common Stock	03/04/2026		S		720⁽¹⁾	D	$285.0287⁽⁸⁾	151,438	D
Common Stock	03/04/2026		S		995⁽¹⁾	D	$286.2013⁽⁹⁾	150,443	D
Common Stock	03/04/2026		S		120⁽¹⁾	D	$286.67⁽¹⁰⁾	150,323	D
Common Stock								42,000	I	By Family Trust⁽¹¹⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 12/03/2025.

2. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $277.99 to $278.35. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

3. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $279.18 to $280.17. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

4. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $280.18 to $281.13. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

5. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $281.36 to $282.34. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

6. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $282.49 to $283.12. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

7. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $283.57 to $284.56. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

8. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $284.57 to $285.45. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

9. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $285.58 to $286.54. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

10. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $286.61 to $286.71. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

11. These shares are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trust.

Remarks:

	/s/ Angelique M. Okeke by Power of Attorney	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did F5 (FFIV) report for its CEO?

F5, INC. reported that President and CEO Francois Locoh-Donou sold 3,755 shares of common stock in open-market transactions on March 4, 2026. These transactions were made under a pre-established Rule 10b5-1 trading plan dated December 3, 2025.

At what prices did the F5 (FFIV) CEO sell his shares?

The CEO’s 3,755-share sale was executed in multiple trades with weighted-average prices reported around the high $270s to mid $280s per share. Footnotes state actual prices ranged from $277.99 to $286.71, with detailed breakouts available upon request from the company or SEC staff.

How many F5 (FFIV) shares does the CEO hold after these sales?

After the reported transactions, Francois Locoh-Donou directly holds 150,323 shares of F5 common stock. In addition, 42,000 shares are held indirectly through a family trust established for his children, where his spouse serves as trustee, according to the filing’s footnotes.

Were the F5 (FFIV) CEO’s stock sales pre-planned?

Yes. The filing notes the transactions were executed pursuant to a Rule 10b5-1 trading plan dated December 3, 2025. Such plans allow insiders to schedule trades in advance, providing a structured framework for selling shares over time, regardless of subsequent company developments.

What is the role of the family trust in the F5 (FFIV) CEO’s holdings?

The filing reports 42,000 shares of F5 common stock are held in a trust for the benefit of the CEO’s children. His spouse serves as trustee of this family trust, and these shares are reported as indirect ownership separate from his directly held shares.

Were the F5 (FFIV) CEO’s transactions open-market sales?

Yes. Each listed trade is coded as an “S” transaction in common stock, described as an open-market or private sale. The filing characterizes these as non-derivative sales of F5 common stock executed on March 4, 2026, under the CEO’s Rule 10b5-1 plan.